Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCL9, also known as monokine induced by gamma interferon (MIG), is a small cytokine belonging to the CXC chemokine family. It is primarily induced by interferon-gamma (IFN-γ) and plays a key role in immune cell recruitment and activation, especially during inflammatory responses. Its interaction with CXCR3 regulates migration, differentiation, and activation of immune cells. CXCL9 can have both pro- and anti-tumor effects depending on the cancer context.
CXCL9 interacts with its receptor CXCR3 to regulate migration, differentiation, and activation of immune cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine C-X-C motif ligand 9 (MIG).